RS

Rita Sharma

Active Director Director DIN 10188683
DIN 10188683 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Rita Sharma

Data last updated:

Rita Sharma is a Director at Ennot Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Ennot Pharmaceuticals Private Limited reported revenue of ₹17.5 Lakh (FY 2025).

DIN 10188683
Primary Designation Director
Industry Pharma
First Appointment 02 Jun 2023
Oldest Company Age 3 yrs
Largest company Ennot Pharmaceuticals Private Limited · ₹17.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Jun 20232023₹17.5 Lakh (FY 2025)Active

Board colleagues of Rita Sharma

NameDINCompanyDesignation
Abhishek Anand10188684Ennot Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ennot Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rita Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rita Sharma

Rita Sharma currently holds 1 directorship: Ennot Pharmaceuticals Private Limited (Director, since 02 Jun 2023, revenue ₹17.5 Lakh (FY 2025)).

Rita Sharma was first appointed on 02 Jun 2023 as Director at Ennot Pharmaceuticals Private Limited.

The current boards of Rita Sharma's companies include Abhishek Anand (Ennot Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available